How to improve the clinical diagnosis of Creutzfeldt-Jakob disease

Brain

Volumn 122, Issue 12, 1999, Pages 2345-2351

  Poser, Sigrid ^a   Mollenhauer, Brit ^b   Krauß, Angela ^b   Zerr, Inga ^b   Steinhoff, Bernhard J ^b   Schroeter, Andreas ^b   Finkenstaedt, Michael ^b   Schulz Schaeffer, Walter J ^b   Kretzschmar, Hans A ^b   Felgenhauer, Klaus ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

14 3 3 protein; Alzheimer's disease; Creutzfeldt Jakob disease; Differential diagnosis; Hashimoto encephalitis

Indexed keywords

PRION PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BLOOD ANALYSIS; BRAIN LYMPHOMA; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATION; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; FOLLOW UP; GERMANY; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRION DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

14-3-3 PROTEINS; ALZHEIMER DISEASE; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINS; REPRODUCIBILITY OF RESULTS; TYROSINE 3-MONOOXYGENASE;

EID: 0032747378     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.12.2345     Document Type: Article

References (24)

1. Arpino C, Conti S, Masocco M, Toccaceli V, Ladogana A, D'Alessandro M, et al. Creutzfeldt-Jakob disease mortality in Italy, 1982-1996. Neuroepidemiology 1999; 18: 92-100.
2. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-29.
3. Felgenhauer K. Laboratory diagnosis of neurological diseases. In: Thomas L, editor. Clinical laboratory diagnostics - use and assessment of clinical laboratory results. Frankfurt: TH-Books; 1998. p. 1308-26.
4. Finkenstaedt M, Szudra A, Zerr I, Poser S, Hise JH, Stoebner JM, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199: 793-8.
5. Ghika-Schmid F, Ghika J, Regli F, Dworak N, Bogousslavsky J, Stadler C, et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition? [see comments]. [Review]. Mov Disord 1996; 11: 555-62. Comment in: Mov Disord 1997; 12:471-2.
6. Ghika-Schmid F, Ghika J, Regli F, Dworak N, Bogousslavsky J, Stadler C, et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition? [see comments]. [Review]. Mov Disord 1996; 11: 555-62. Comment in: Mov Disord 1997; 12:471-2.
7. Hainfellner JA, Jellinger K, Diringer H, Guentchev M, Kleinert R, Pilz P, et al. Creutzfeldt-Jakob disease in Austria. J Neurol Neurosurg Psychiatry 1996; 61: 139-42.
8. Hsich G, Kenney K, Gibbs CJ. Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies [see comments]. N Engl J Med 1996; 335: 924-30. Comment in: N Engl J Med 1996; 335: 963-5, Comment in: N Engl Med 1997; 336: 873-5, Comment in: ACP J Club 1997; 126: 45.
9. Hsich G, Kenney K, Gibbs CJ. Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies [see comments]. N Engl J Med 1996; 335: 924-30. Comment in: N Engl J Med 1996; 335: 963-5, Comment in: N Engl Med 1997; 336: 873-5, Comment in: ACP J Club 1997; 126: 45.
10. Hsich G, Kenney K, Gibbs CJ. Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies [see comments]. N Engl J Med 1996; 335: 924-30. Comment in: N Engl J Med 1996; 335: 963-5, Comment in: N Engl Med 1997; 336: 873-5, Comment in: ACP J Club 1997; 126: 45.
11. Hsich G, Kenney K, Gibbs CJ. Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies [see comments]. N Engl J Med 1996; 335: 924-30. Comment in: N Engl J Med 1996; 335: 963-5, Comment in: N Engl Med 1997; 336: 873-5, Comment in: ACP J Club 1997; 126: 45.
12. Johnson RT, Gibbs CJ. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998; 339: 1994-2004.
13. Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. [Review]. J Neurol 1996; 243: 585-93.
14. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 913-20.
15. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177-88.
16. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35: 453-61.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 934-44.
18. Seipelt M, Zerr I, Nau R, Mollenhauer B, Kropp S, Steinhoff BJ, et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1999; 66: 172-6.
19. Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 162-6.
20. Watson CP. Clinical similarity of Alzheimer and Creutzfeldt-Jakob disease. Ann Neurol 1979; 6: 368-9.
21. Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: clinical features. J Neurol Neurosurg Psychiatry 1984; 47: 134-40.
22. Will R, Zeidler M. Diagnosing Creutzfeldt-Jakob disease [editorial]. BMJ 1996; 313: 833-4.
23. Will RG, Alpérovitch A, Poser S, Pocchiari M, Hofman A, Mitrova E, et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. Ann Neurol 1998; 43: 763-7.
24. Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43: 32-40.